Benzonatate
Tessalon (benzonatate) is a small molecule pharmaceutical. Benzonatate was first approved as Tessalon on 1982-01-01. It is used to treat cough and hiccup in the USA.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Tessalon (generic drugs available since 1993-01-29)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Benzonatate
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TESSALON | Mylan | N-011210 RX | 1982-01-01 | 1 products, RLD |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
benzonatate | ANDA | 2023-06-08 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
cough | HP_0012735 | D003371 | R05 |
hiccup | — | D006606 | R06.6 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | BENZONATATE |
INN | benzonatate |
Description | Benzonatate is the ester obtained by formal condensation of 4-butylaminobenzoic acid with nonaethylene glycol monomethyl ether. Structurally related to procaine and benzocaine, it has an anaesthetic effect on the stretch sensors in the lungs, and is used as a non-narcotic cough suppressant. It has a role as an antitussive and an anaesthetic. It is a benzoate ester, a substituted aniline and a secondary amino compound. It is functionally related to a 4-(butylamino)benzoic acid and a nonaethylene glycol monomethyl ether. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1 |
Identifiers
PDB | — |
CAS-ID | 104-31-4 |
RxCUI | 18993 |
ChEMBL ID | CHEMBL1374379 |
ChEBI ID | 3032 |
PubChem CID | 7699 |
DrugBank | DB00868 |
UNII ID | 5P4DHS6ENR (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 213 documents
View more details
Safety
Black-box Warning
Black-box warning for: Benzonatate
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more